Cardiol Therapeutics
(NASDAQ) CRDL
Cardiol Therapeutics Financials at a Glance
Market Cap
$152.15M
Revenue (TTM)
$0.00
Net Income (TTM)
$33.82M
EPS (TTM)
$-0.28
P/E Ratio
-4.86
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$1.41
Volume
266,206.949
Open
$1.37
Price
$1.41
Volume
266,206.949
Open
$1.37
Previous Close
$1.36
Daily Range
$1.34 - $1.43
52-Week Range
$0.88 - $1.71
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$1.41
Volume
266,206.949
Open
$1.37
Previous Close
$1.36
Daily Range
$1.34 - $1.43
52-Week Range
$0.88 - $1.71
CRDL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cardiol Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
23
CEO
David G. Elsley, MBA
Website
www.cardiolrx.comHeadquarters
Oakville, ON L6H 0G5, CA
CRDL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-160%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-20.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$152.15M
Shares Outstanding
111.87M
Volume
266.21K
Short Interest
0.00%
Avg. Volume
657.96K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$34.32M
EBITDA
$34.21M
Operating Cash Flow
$23.85M
Capital Expenditure
$24.48K
Free Cash Flow
$23.88M
Cash & ST Invst.
$21.42M
Total Debt
$125.52K
Cardiol Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$25.95K
+23.0%
Gross Margin
0.00%
N/A
Market Cap
$152.15M
N/A
Market Cap/Employee
$8.45M
N/A
Employees
18
N/A
Net Income
$7.21M
-26.9%
EBITDA
$8.00M
-41.7%
Quarterly Fundamentals
Net Cash
$21.29M
-30.0%
Accounts Receivable
$226.19K
-37.4%
Inventory
$0.00
N/A
Long Term Debt
$87.18K
-30.5%
Short Term Debt
$38.35K
+16.2%
Return on Assets
-1.43%
N/A
Return on Invested Capital
-1.91%
N/A
Free Cash Flow
$5.23M
+6.6%
Operating Cash Flow
$5.23M
+6.6%